Lupin’s partner ForDoz receives USFDA approval for doxorubicin hydrochloride liposome injection
Doxorubicin Hydrochloride Liposome Injection (RLD Doxil) had estimated annual sales of USD 42 million in the U.S. (IQVIA MAT May 2024)
Doxorubicin Hydrochloride Liposome Injection (RLD Doxil) had estimated annual sales of USD 42 million in the U.S. (IQVIA MAT May 2024)
Multidisciplinary central team deployed to assist Gujarat with epidemiological, environmental, and laboratory investigations of AES cases
Finance Minister Nirmala Sitharaman is set to present the full budget for the current financial year on July 23
The pooled prevalence of GERD in the Indian population is 15.6 %
Lupin can receive a potential total consideration of up to USD 84 million based on future contingent milestones
The inspection closed with five observations which were more of procedural changes with none of these related to data integrity
The company will address these observations within the stipulated timeline
Selexipag is a prostacyclin receptor agonist indicated for the treatment of pulmonary arterial hypertension
The company is planning to expand its plant capacity in in Vapi
Subscribe To Our Newsletter & Stay Updated